Tumor-associated macrophages mediate resistance of EGFR-TKIs in non-small cell lung cancer: mechanisms and prospects

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) are the first-line standard treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutation. However, resistance to EGFR-TKIs is inevitable. Currently, most studies on the mechanism of EGFR-TKIs resistance mainly fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Daoan, Ge, Kele, Yao, Xue, Wang, Banglu, Chen, Rui, Zhao, Weiqing, Fang, Cheng, Ji, Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463184/
https://www.ncbi.nlm.nih.gov/pubmed/37649478
http://dx.doi.org/10.3389/fimmu.2023.1209947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463184/
https://www.ncbi.nlm.nih.gov/pubmed/37649478
http://dx.doi.org/10.3389/fimmu.2023.1209947

Ejemplares similares